ASX:ATH

Email Alerts for:
ASX:ATH

Information technology sector slides 3%: ASX closes 1.6% higher

07 Jan 2021 - It has been a terrific day of trade for the ASX. After opening modestly higher, the ASX 200 shot up in the first 10 minutes of trade, then gained momentum at a steady…

Alterity Therapeutics (ASX:ATH) appoints new CEO

07 Jan 2021 - Alterity Therapeutics (ASX:ATH) has appointed Dr David Stamler as chief executive officer to start today.

Alterity Therapeutics (ASX:ATH) Presentation, FNN Online Investor Event, December 2020

09 Dec 2020 - Alterity Therapeutics Limited (ASX:ATH) Chairman and CEO Geoffrey Kempler presents an overview of the company, discussing Parkinsonian disorders, progress with the co…

Alterity Therapeutics (ASX:ATH) targeting Multiple System Atrophy

09 Dec 2020 - Alterity Therapeutics Limited (ASX:ATH) Chairman and CEO Geoffrey Kempler provides an update on the company's lead compound ATH434 for Multiple System Atrophy, its du…

Alterity Therapeutics (ASX:ATH) Presentation, FNN Investor Event, June 2019, Sydney

09 Jul 2019 - Alterity Therapeutics Limited (ASX:ATH) CEO & Chairman, Geoffrey Kempler, presents on the company's lead drug candidate, the potential applications for the drug and t…

Alterity Therapeutics (ASX:ATH) - treating neurological disease

09 Jul 2019 - Alterity Therapeutics Limited (ASX:ATH) CEO & Chairman, Geoffrey Kempler, discusses the company’s development pipeline and lead drug candidate PTB434 for use treating…